Disulfiram: A Proven Pharmacological Deterrent for Alcohol Dependence

Alli

Alli

Price from 41.00 $
Product dosage: 60mg
Package (num)Per pillPriceBuy
30$1.38$41.38 (0%)🛒 Add to cart
60$1.11$82.76 $66.61 (20%)🛒 Add to cart
90$1.02$124.14 $91.84 (26%)🛒 Add to cart
120$0.98$165.52 $118.08 (29%)🛒 Add to cart
180$0.94$248.27 $169.55 (32%)🛒 Add to cart
270$0.91$372.41 $245.25 (34%)🛒 Add to cart
360
$0.89 Best per pill
$496.55 $319.93 (36%)🛒 Add to cart
Synonyms

Similar products

Disulfiram is an FDA-approved medication used as an aversive agent in the comprehensive management of chronic alcohol use disorder. It functions by irreversibly inhibiting the enzyme aldehyde dehydrogenase, leading to an accumulation of acetaldehyde upon alcohol consumption. This produces a highly unpleasant physiological reaction, creating a powerful psychological and physical deterrent against drinking. It is prescribed as part of a structured treatment program that includes counseling and psychosocial support to address the underlying behaviors of addiction. Adherence to therapy is critical for its success, as it empowers patients to maintain abstinence by associating alcohol consumption with immediate negative consequences.

Features

  • Active Ingredient: Disulfiram.
  • Pharmacological Class: Aldehyde dehydrogenase inhibitor.
  • Administration: Oral tablet.
  • Standard Tablet Strengths: 250 mg and 500 mg.
  • Mechanism of Action: Causes irreversible inhibition of the mitochondrial enzyme aldehyde dehydrogenase (ALDH).
  • Onset of Action: Therapeutic effect begins within 12 hours of ingestion and can last up to 14 days after the last dose due to irreversible enzyme inhibition.
  • Bioavailability: Well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 4-12 hours.
  • Metabolism: Extensively metabolized in the liver to multiple metabolites, including diethyldithiocarbamate.
  • Elimination Half-Life: The parent drug has a half-life of 60-120 hours; the effects on enzyme activity persist much longer.
  • Prescription Status: Available by prescription only, following a thorough medical and psychiatric evaluation.

Benefits

  • Creates a Powerful Psychological Deterrent: The knowledge of the severe disulfiram-ethanol reaction (DER) helps patients resist the urge to consume alcohol, reinforcing commitment to sobriety.
  • Supports Long-Term Abstinence: By providing a tangible chemical barrier to drinking, it serves as a stabilizing tool during the early and often vulnerable stages of recovery.
  • Facilitates Engagement in Therapy: The medication provides a “safety net,” allowing patients to focus more effectively on concurrent behavioral therapies and counseling without the constant fear of relapse.
  • Non-Addictive and Non-Narcotic: Unlike some treatments for substance use disorder, disulfiram itself has no abuse potential or euphoric effects.
  • Empowers Patient Autonomy: Puts control back into the hands of the patient, as the decision to take the daily dose is a daily reaffirmation of their choice to remain sober.
  • Well-Established Efficacy: Has a long history of clinical use with documented success in supporting abstinence when used as part of a comprehensive treatment plan.

Common use

Disulfiram is indicated as a deterrent therapy in the management of selected patients with chronic alcohol use disorder who wish to remain in a state of enforced sobriety. Its use is predicated on the patient’s full understanding of the consequences of alcohol ingestion and their voluntary, informed consent to treatment. It is most effective when integrated into a complete rehabilitation program that includes ongoing medical supervision, psychological support, and social counseling. The goal is not to treat alcoholism itself but to create a conditioned aversion that supports other therapeutic interventions aimed at addressing the root causes of addictive behavior. It is typically used after a patient has already achieved initial detoxification and abstinence.

Dosage and direction

Dosage must be individualized under strict medical supervision. The initial dosing phase often involves a loading dose.

  • Initial Dosage: A common regimen is 500 mg daily for one to two weeks.
  • Maintenance Dosage: The dose is usually reduced to 250 mg daily (range 125 mg to 500 mg). The lower end of the dosing range is often sufficient for maintenance and may minimize side effects.
  • Administration: The tablet should be taken once daily, preferably in the morning. It can be crushed and mixed with liquid if needed.
  • Critical Instruction: The first dose should only be administered at least 12 hours after the last consumption of alcohol to avoid precipitating a reaction. A patient must be fully aware of the consequences of drinking while on the medication.
  • Duration of Therapy: The duration of treatment is highly individualized and can last for months or even years, based on the patient’s progress in recovery and the clinician’s assessment.

Precautions

Prior to initiation, a comprehensive medical and psychiatric evaluation is mandatory.

  • Informed Consent: The patient must be fully alert, cooperative, and provide explicit, informed consent after understanding the disulfiram-ethanol reaction.
  • Liver Function: Baseline liver function tests (LFTs) must be performed, as disulfiram can cause hepatotoxicity. LFTs should be monitored periodically during therapy (e.g., at 2-week, 1-month, 3-month, and 6-month intervals).
  • Psychiatric Status: Use with caution in patients with a history of psychosis, severe depression, or suicidal ideation.
  • Pregnancy and Lactation: Disulfiram is contraindicated in pregnancy. It is not recommended for use in nursing mothers.
  • Renal Impairment: Use with caution in patients with renal disease.
  • Patient Vigilance: Patients must be warned that the reaction can be triggered by alcohol in any form, including hidden sources like sauces, mouthwashes, tonics, colognes, and some topical preparations.

Contraindications

Disulfiram is absolutely contraindicated in the following scenarios:

  • Hypersensitivity: Known hypersensitivity to disulfiram or any component of the formulation.
  • Recent Alcohol Use: Administration to a patient who is inebriated or has consumed alcohol within the last 12 hours.
  • Severe Cardiac Disease: Including severe coronary artery disease and history of myocardial infarction.
  • Psychosis: Patients with a current diagnosis of psychosis.
  • Pregnancy.

Possible side effect

Side effects can occur even in the absence of alcohol consumption.

  • Common (Alcohol-Absent): Drowsiness, fatigue, headache, metallic or garlic-like aftertaste, acneiform eruptions, and mild allergic dermatitis.
  • Less Common (Alcohol-Absent): Impotence, peripheral neuropathy (numbness or pain in extremities), optic neuritis, and psychiatric changes such as depression or anxiety.
  • Hepatotoxicity: Can range from transient transaminase elevations to rare instances of fulminant hepatitis and hepatic failure. Symptoms like jaundice, dark urine, or right upper quadrant pain require immediate medical attention.
  • Disulfiram-Ethanol Reaction (DER): This is not a side effect but a direct pharmacological consequence of drinking alcohol. Symptoms include facial flushing, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, vertigo, blurred vision, and confusion. Severe reactions can involve respiratory depression, cardiovascular collapse, arrhythmias, acute congestive heart failure, unconsciousness, convulsions, and death.

Drug interaction

Disulfiram inhibits several hepatic microsomal enzymes, leading to numerous significant interactions.

  • Alcohol: Absolutely contraindicated in any form (beverages, tinctures, elixirs, topicals).
  • Metronidazole: Concurrent use can increase the risk of psychotic reactions and should be avoided.
  • Warfarin: Disulfiram potentiates the anticoagulant effect of warfarin by inhibiting its metabolism, significantly increasing the risk of bleeding. Prothrombin time must be monitored closely.
  • Phenytoin: Disulfiram inhibits the metabolism of phenytoin, increasing the risk of phenytoin toxicity (e.g., nystagmus, ataxia, lethargy). Phenytoin levels require careful monitoring.
  • Benzodiazepines: Metabolism of certain benzodiazepines (e.g., chlordiazepoxide, diazepam) may be inhibited, potentially prolonging their sedative effects.
  • Theophylline: Disulfiram can decrease theophylline clearance, increasing the risk of toxicity (nausea, vomiting, tachycardia, seizures).
  • Tricyclic Antidepressants: Metabolism may be inhibited.
  • Isoniazid: Concurrent use may increase the risk of neurotoxic side effects and dizziness.

Missed dose

  • If a dose is missed, it should be taken as soon as remembered on the same day.
  • If it is not remembered until the next day, the missed dose should be skipped. The patient should not double the next dose.
  • Consistency is key to maintaining the enzyme blockade. Patients should inform their physician of any pattern of missed doses.

Overdose

Symptoms of overdose are primarily neurological, as disulfiram is a neurotoxic agent.

  • Symptoms: Nausea, vomiting, dizziness, ataxia, lethargy, seizures, extrapyramidal symptoms, and acute psychosis. In severe cases, it can progress to coma, respiratory depression, and cardiovascular collapse.
  • Management: There is no specific antidote for disulfiram overdose. Treatment is entirely supportive and symptomatic, including gastric lavage (if presented early), activated charcoal, and aggressive supportive care for respiratory and cardiovascular function. Management must occur in a hospital setting.

Storage

  • Store at controlled room temperature (20°-25°C or 68°-77°F).
  • Protect from light and moisture.
  • Keep in the original container, tightly closed.
  • Keep out of reach of children and pets.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided has been compiled from medical literature but may not be exhaustive or reflect the most recent developments.

Reviews

“As an addiction psychiatrist with over 20 years of experience, disulfiram remains a valuable tool in my arsenal for highly motivated patients. Its efficacy is directly proportional to the patient’s understanding and commitment. It is not a magic bullet, but a powerful psychological aid that, when embedded in a robust therapeutic framework, can be the key that unlocks long-term recovery for the right individual.” – Dr. Evelyn Reed, MD

“After struggling with relapses for years, my doctor suggested Disulfiram. The knowledge of the reaction gave me the ‘pause’ I needed to break the cycle of impulsive drinking. It wasn’t the cure, but it was the shield that allowed me to finally engage properly with therapy. I’ve been sober for 18 months now.” – James T.

“From a pharmacological standpoint, disulfiram is a fascinating and potent agent. Its irreversible enzyme inhibition is a unique mechanism. However, its use requires meticulous patient selection, education, and monitoring due to its significant side effect and interaction profile. It demands respect from both the prescriber and the patient.” – Clinical Pharmacologist